ARK-FutureFirst
Edited
๐Ÿงฌ ๐™†๐™ฃ๐™ค๐™ฌ ๐™”๐™ค๐™ช๐™ง ๐™‚๐™š๐™ฃ๐™ค๐™ข๐™ž๐™˜๐™จ ๐™€๐™ญ๐™ฅ๐™ค๐™จ๐™ช๐™ง๐™š: ๐™’๐™๐™ฎ ๐™”๐™ค๐™ช๐™ง ๐™ƒ๐™š๐™–๐™ก๐™ฉ๐™๐™˜๐™–๐™ง๐™š ๐˜ผ๐™ก๐™ก๐™ค๐™˜๐™–๐™ฉ๐™ž๐™ค๐™ฃ ๐™ˆ๐™ž๐™œ๐™๐™ฉ ๐˜ฝ๐™š ๐™๐™ฃ๐™›๐™ž๐™ฉ ๐™๐™ค๐™ง ๐™๐™๐™š ๐™๐™ช๐™ฉ๐™ช๐™ง๐™š Traditional healthcare allocations may not be keeping pace with the innovation transforming the sector. Weโ€™re no longer in a world of reactive sickcare โ€” weโ€™re entering the era of P4 medicine: ๐Ÿ”น Preventive ๐Ÿ”น Predictive ๐Ÿ”น Personalized ๐Ÿ”น Participatory Driven by the convergence of AI, multiomics, and precision medicine, healthcare is becoming a truly data-driven science โ€” reshaping everything from early diagnostics to curative therapies. ๐Ÿ“Š In its latest report, ARK Invest Europe challenges investors to rethink how they measure exposure to this revolution. Genomics is not just a healthcare story โ€” itโ€™s a cross-sector disruption reshaping the future of medicine. ๐Ÿ“ฅ ๐™๐™š๐™–๐™™ ๐™ฉ๐™๐™š ๐™›๐™ช๐™ก๐™ก ๐™ง๐™š๐™ฅ๐™ค๐™ง๐™ฉ: ๐™†๐™ฃ๐™ค๐™ฌ ๐™”๐™ค๐™ช๐™ง ๐™‚๐™š๐™ฃ๐™ค๐™ข๐™ž๐™˜๐™จ ๐™€๐™ญ๐™ฅ๐™ค๐™จ๐™ช๐™ง๐™š โ€“ ๐˜ผ๐™๐™† ๐™„๐™ฃ๐™ซ๐™š๐™จ๐™ฉ ๐™€๐™ช๐™ง๐™ค๐™ฅ๐™š europe.ark-funds.com/insights/research-insights/
Like CommentShare
null
.